Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the nine analysts that are covering the company, Marketbeat reports. Three equities research analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is $87.44.
ACHC has been the subject of several research reports. Deutsche Bank Aktiengesellschaft raised their price objective on shares of Acadia Healthcare from $70.00 to $75.00 and gave the company a “hold” rating in a research report on Friday, August 2nd. Cantor Fitzgerald reiterated a “neutral” rating and issued a $90.00 price objective on shares of Acadia Healthcare in a research report on Monday, August 19th. StockNews.com downgraded Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Tuesday, May 21st. Barclays decreased their price target on Acadia Healthcare from $89.00 to $83.00 and set an “overweight” rating on the stock in a report on Thursday, August 1st. Finally, Royal Bank of Canada restated an “outperform” rating and set a $94.00 target price on shares of Acadia Healthcare in a research report on Wednesday, May 22nd.
Read Our Latest Report on ACHC
Institutional Inflows and Outflows
Acadia Healthcare Stock Performance
Acadia Healthcare stock opened at $77.77 on Wednesday. The stock has a fifty day moving average price of $72.61 and a two-hundred day moving average price of $72.09. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.18 and a quick ratio of 1.18. Acadia Healthcare has a 52-week low of $62.04 and a 52-week high of $87.77. The firm has a market capitalization of $7.22 billion, a P/E ratio of -555.50, a P/E/G ratio of 2.22 and a beta of 1.30.
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last released its quarterly earnings results on Wednesday, July 31st. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.87 by $0.04. The business had revenue of $796.00 million for the quarter, compared to analyst estimates of $784.38 million. Acadia Healthcare had a positive return on equity of 11.42% and a negative net margin of 0.17%. Acadia Healthcare’s revenue for the quarter was up 8.8% on a year-over-year basis. During the same period in the prior year, the company earned $0.92 EPS. As a group, analysts anticipate that Acadia Healthcare will post 3.51 EPS for the current fiscal year.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Read More
- Five stocks we like better than Acadia Healthcare
- P/E Ratio Calculation: How to Assess Stocks
- Galmed Pharmaceuticals Surges 400%: What’s Behind the Explosion?
- Ride Out The Recession With These Dividend KingsĀ
- Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Intel: Why It’s Time to Reconsider This Beaten-Down Chipmaker
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.